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Abstract
Evolutionary developmental biology has historically used generalist model organisms like
Drosophila melanogaster. The Hawaiian Drosophilidae radiation, which occurred just 25 million
years ago, is an ideal lineage for work in Evo-Devo. Hawaiian flies make up 25% of the world’s
Drosophila species and extreme diversity is seen throughout the group. D. grimshawi is a
generalist Hawaiian picture-wing fly that has served as a model for the Hawaiian Drosophilidae
radiation. However, D. grimshawi’s power and use as a model organism is constrained by our
lack of ability to manipulate its genome. In this work, I attempted to edit the genome of D.
grimshawi for the first time using a novel CRISPR/Cas9 delivery method known as ReMOT
Control. However, my preliminary results may suggest that use of the DmP2C ligand for delivery
of the CRISPR/Cas9 components causes injected D. grimshawi females to become transiently
sterile, preventing genome editing from occurring with ReMOT Control.
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Introduction and Background
A central goal of Evolutionary Developmental Biology (Evo-Devo) is to connect an
organism’s developmental variation to its broader evolutionary context1,2. Researchers seek to
associate changes in genes to changes in phenotypes at the species level and above. However,
questions relevant to Evo-Devo have historically required the development of a substantial set
of molecular tools for their elucidation. This has biased the last half century of Evo-Devo
research to only a few model organisms. The insect “super model organism” Drosophila
melanogaster has been essential to our understanding of the complex spatial and temporal
gene regulatory pathways required during embryonic development. However, D. melanogaster
is an arguably poor model species from an evolutionary perspective. D. melanogaster is a
generalist, cosmopolitan species in a group further dominated by generalist species with low
rates of lineage diversification3, whereas an ideal Evo-Devo model clade is diverse at both the
inter- and intra-species levels4.
An ideal species for Evo-Devo research is the Hawaiian picture-wing Drosophila,
Drosophila grimshawi (Figure 1). D. grimshawi has become the proverbial “Drosophila
melanogaster” of the incredibly diverse Hawaiian Drosophila radiation, but there are still
significantly fewer resources available to study D. grimshawi’s dazzling molecular evolutionary
history. The lack of molecular tools developed for non-model organisms like D. grimshawi, and
thus the gap in Evo-Devo research in diverse lineages, is problematic because it provides us
with a limited perspective of the variation of life of earth and how that variation may have
arisen. My research focused on developing a viable CRISPR/Cas9 gene editing approach in D.
grimshawi to aid in future research on this species, and to lay the groundwork for developing
the approach in other Hawaiian Drosophilidae species.
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Figure 1. Hawaiian Drosophilidae are an ideal lineage for Evo-Devo research. A. Comparison of an adult D. melanogaster
fly (left) to an adult D. grimshawi fly (right). b. Map of the Hawaiian Islands with approximate island age in millions of
years. Arrows show the colonization events that are proposed to have occurred on the islands to account for the
evolutionary relationships of the Hawaiian picture-wing group. C. Phylogeny composed of 17 Hawaiian Drosophilidae
species, including 4 Scaptomyza, 1 modified mouthparts, and 12 picture-wing species with D. melanogaster as the
outgroup. Asterisks denote an ecological specialist species.

Hawaiian Drosophila
Approximately one quarter of all Drosophila species are endemic to the Hawaiian
Islands. This massive adaptive radiation of Drosophilids was driven by a single colonization
event that occurred just 26 million years ago. Today, there are an estimated 1000 extant
species that make up the group collectively known as Hawaiian Drosophilidae4,5. They are an
ideal lineage for studies in evo-devo because of their extreme diversity, close genetic
relationships, and high occurrences of specialist species (figure 1C).
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Within Hawaiian Drosophilidae there are two monophyletic groups, the Hawaiian
Drosophila proper (hence forth referred to as, Hawaiian Drosophila) and Scaptomyza. The
Scaptomyza genus includes nearly 330 described species, most of which are endemic to the
Hawaiian Islands5. However, remarkably, the lineage has been able to escape Hawaii and
colonize the mainland5. In contrast, Hawaiian Drosophila have remained exclusively on the
Hawaiian Islands. Hawaiian Drosophila are divided into four clades, the haleakalae species
group, the AMC clade (antopocerus, modified-tarsus, ciliated-tarsus), the modified mouthparts
group, and the PNA clade (picture-wing, nudidrosophila, ateledrosophila) 4,6.
The extreme morphological diversity of this clade inspired a multidisciplinary effort to
elucidate their evolution and rapid speciation. Studies have looked at everything from their
larval ecology5, secondary sexual characteristics7,8, host plant specificity9, ovariole number3,10,11,
polytene chromosomes12, to size variation6. Hampton Carson, one of the first purveyors of
Hawaiian Drosophila research assembled the first phylogeny for the group12 using polytene
chromosomes. Recent molecular evidence has resolved the phylogenetic relationships between
the four major clades of Hawaiian Drosophila. The work indicated that the PNA clade, was the
first clade to diverge from the Hawaiian Drosophila group and serves as the sister clade to all
other Hawaiian Drosophila clades6. The rapid adaptation and speciation that has occurred in
Hawaiian Drosophilidae has happened with minimal coding sequence divergence8,13 making
comparative studies considerably easier. Furthermore, there are many instances of species
pairs of Hawaiian Drosophilidae that can produce viable hybrid offspring. Previous research has
used quantitative trait loci mapping and RNA-seq with hybrid individuals to identify a bevy of
candidate genes that may play a significant role in speciation in the Drosophila radiation14,15.
The Hawaiian picture wing group, classified under the PNA clade, diversified just 5
million years ago6. There are 120 described species that make up the incredibly diverse, affable
group8. Picture wing species are significantly larger than mainland flies with intricate wing
pigmentation patterns. Most picture wing species are specialist bark breeders that utilize a
favored native plant for oviposition16. Studies have indicated that picture wing speciation has
been significantly influenced by secondary sexual characteristics 7,14,17. Female mate choice is
highly impacted by the use of lek mating systems, wherein male flies dance for female choice
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and provide no parental input7. During these dances, differences in something as minor as wing
beat frequency can make or break a male’s chance of mating. For closely related species this
tends to be more pronounced in sympatric species pairs18.
Despite the extensive work conducted on Hawaiian flies, few molecular tools have been
developed for use in this group. Edwards et al., 2007 discussed why Hawaiian Drosophila are a
tractable lineage for work in developmental biology. They define a tractable group as one
where transgenic organisms can be generated and suggest that protocols for such work in
Hawaiian Drosophila have already been established8. They are referring here to a 1984 study on
the use of P element transformation in the Hawaiian Drosophila species, Drosophila
hawaiiensis. While the results indicated P elements can be transformed and retained in the D.
hawaiiensis germline, no further studies were conducted19. This indicates significant
development and validation of such tools for Hawaiian Drosophilidae are still needed.

Drosophila grimshawi: The model Hawaiian Drosophila fly
The Hawaiian picture wing species, Drosophila grimshawi stands out as a generalist
anomaly among a group of specialists. The fly is one of just seven multi-island endemic picture
wing flies, and it is found throughout the Maui Nui island complex20. However, originally D.
grimshawi was believed to inhabit every Hawaiian island,20 until crosses between populations
on Hawaii to populations on Maui produced sterile hybrid offspring. It was determined that
individuals on Hawaii were a separate, specialist species now known as, D. pullipes21. Later, a
combination of genetic and morphological data revealed individuals on Oahu and Kauai first
believed to be D. grimshawi were also shown to be a different, distinct, specialist species now
known as, D. craddockae15. Notably, this study observed that differences in male D. grimshawi
mating behavior prevented all hybrid crosses with female D. craddockae flies15.
In line with its generalist behaviors, D. grimshawi has been reared successfully on more
than ten plant species and was the first Hawaiian Drosophila to be successfully cultured20. D.
grimshawi, and the picture-wing group in general, have a significantly longer lifespan and
development time when compared to more commonly studied Drosophila species. Time from
egg to a sexual maturity in D. grimshawi is roughly 1 to 1.5 months. While considerable time
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and effort is required to obtain adult D. grimshawi flies, researchers are rewarded with the
adult fly’s long lifespan and high fecundity. Under ideal laboratory conditions, adult female D.
grimshawi flies are able to survive and remain fertile for up to a year20. In 2007, D. grimshawi
became the first Hawaiian Drosophila to have its genome sequenced22. While genome
engineering work can be accomplished in species lacking whole genome assemblies, having a
reference assembly available makes designing and implementing a project of this nature
significantly easier. Despite the large body of research on D. grimshawi, a robust molecular
toolkit has not been developed for this species. It is for these reasons that I chose D. grimshawi
for this study.

The Unique Embryonic Gene Expression of Hawaiian Drosophilidae
Major developments in Next Generation Sequencing (NGS) as well as genome
engineering has launched us into the “-omics” era of research. However, NGS studies in nonmodel organisms have further highlighted the need to develop molecular tools for the
functional characterization of candidate genes following a sequencing project 23. The Atallah lab
has previously used RNA-seq to investigate the gene expression profile in the early embryo of
D. grimshawi as well as Scaptomyza anomala and Scaptomyza elmoi. During embryonic
development, early zygotic transcripts tend to be highly varied, evolutionarily younger, and
potentially species specific24. Rapid cellular divisions during the onset of embryogenesis may
play a role in this variation due to the dramatically shorter cell cycle inhibiting the zygote’s
ability to produce long transcripts24. Transcriptomic comparisons of zygotically derived mRNA in
mouse, fly, and Zebrafish found the average transcript length was significantly shorter during
early embryogenesis than any other time in development24. This suggests early zygotic
transcription is a more evolutionarily malleable time in development. Further, studies have
discovered unique sets of microRNAs25 and transcription factors 26 present only during early
embryonic development, indicating that early embryonic stages may act as a potential source
of variation for adaptation and evolution.
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Our work indicated that D. grimshawi’s early embryonic gene expression is highly
divergent from mainland flies27. In fact, the only species whose gene expression was found to
be more divergent than D. grimshawi was our outgroup, the mosquito, Aedes aegypti. We
further analyzed the data to determine if we could
identify which genes were exhibiting such
divergent expression patterns in D. grimshawi’s
early embryo. One gene we were able to annotate
was, multiple wing hairs (mwh)27. mwh is a
downstream component of the frizzled signaling
pathway which controls planar cell polarity28,29.
mwh is known to be responsible for antagonizing
the actin cytoskeleton during

development28.

Figure 2. Early embryonic representation of mwh
gene across 8 Drosophila species (adapted from
Chenevert 2019)

However, the novel expression of mwh that we
observed in D. grimshawi’s early embryo, which was greater than 10-fold higher expression at
embryonic stage 5 when compared to seven mainland species, suggests that mwh may have a
novel role during embryonic development in D. grimshawi that is not yet understood (Figure 2).
Further analysis of the early embryonic gene expression data also revealed that a
significant proportion of our assembly is composed of unannotated transcripts which are not
present in mainland species30. However, we have found instances of similar transcripts in other
Hawaiian Drosophila and Scaptomyza species including our early embryonic transcriptome
assemblies of S. anomala and S. elmoi 30. This indicates that some of these transcripts may be
novel genes that arose during Hawaiian Drosophila evolution. However, to be able to confirm
the functional impact of mwh or the unannotated transcripts, we first need to develop tools for
direct genetic analysis in D. grimshawi. To my knowledge, no study to date has successfully
mutated D. grimshawi’s genome. Thus, the development of an effective gene editing tool for
D. grimshawi to further investigate our candidate genes was the catalyst for this research. Not
only would this tool aid in filling the gaps in our understanding of early embryonic development
in D. grimshawi, but it would also expand the research questions that could be explored in this
species, laying the groundwork for developing these tools in other Hawaiian Drosophila species.
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Insect Genome Engineering: History and Techniques
One of the first major breakthroughs in insect genome editing and engineering was the
discovery of P transposable elements and their subsequent use in transposon mediated
transformation. P elements are mobile genetic elements that invaded wild populations of D.
melanogaster more than a century ago31. They use cut-and-paste transposition to jump to new
locations in the genome, exclusively in germline cells, catalyzed by an endogenous
transposase31. Transposition occurs nonrandomly at genomic locations that are chromosomally
accessible, and GC-rich, which tends to occur at the 5’ end of genes or near a promoter31,32.
Transposon mediated gene editing began after researchers discovered that the
transposase gene could be removed from the P element and replaced by a gene of interest. If
the construct was then co-injected with an exogenous source of transposase into preblastoderm embryos, the P element would function normally and incorporate itself into the
genome33. In its earliest iteration, researchers designed a P element construct carrying the
bacterial reporter gene, LacZ and the D. melanogaster rosy [ry+] gene, both under the control
of the weak P element promoter33. Injections were done using null mutant rosy flies and
successful transformants were identified by the presence of rose-colored eyes. This indicated
the P element had inserted itself downstream of an expression element in the Drosophila
genome.
Research on P elements outside of Drosophila have indicated that the technology is not
broadly applicable, and is only functional in a few species34. However, another cut-and-paste
transposon known as piggyBac was discovered in the cabbage looper moth (Trichoplusia ni) in
1984. PiggyBac mediated transformation has been successful in many different species
including non-Drosophila insects, mammals, and fungi and has been demonstrated to be active
in plants. It has become the current standard for transposon mediated transformation34.
In comparison to more recently developed genome engineering technologies,
transposon mediated transformation has significant drawbacks. Both piggyBac and P elements
are limited by their lack of customization. Insertion of the transposon can occur multiple times
at different loci and a gene of interest cannot be specifically targeted34. Further, most
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experimental approaches rely on a marker gene, like D. melanogaster rosy, to confirm
successful integration of the construct into the genome33. To my knowledge, there are no
mutant lines of D. grimshawi currently available that could be used for this purpose. While
exogenous marker genes like GFP have been used in other species, their use has the potential
to confound results32. Historically, experiments have relied on the assumption that the reporter
or marker gene expression mimics that of the trapped gene, but this is not always the case32.
Different reporter genes, including GFP, may exhibit delayed activity or greater expression than
the endogenous gene. Additionally, the construct may be influenced by its orientation on the
DNA strand as well as its distance from the enhancer of interest which could lead to divergent
expression of the reporter gene32. Thus, while this approach has undergone the most
development for genome editing in Hawaiian Drosophila species, I opted to use more
customizable technology for this project.
Following transposon mediated transformation, site-specific genome engineering was
developed which enabled genes to be targeted at will, this has provided researchers with
greater control and customization. The most popular of these approaches are site-specific DNA
breakage technologies which exploit the endogenous DNA repair machinery to generate a
desired mutant by inducing a double strand break (DSB) in the organism’s DNA. When DSBs are
repaired, one of two mechanisms are utilized by the cell, non-homologous end joining (NHEJ) or
homology directed repair (HDR). Both mechanisms can be exploited to generate mutations at a
desired target site.
NHEJ is an error prone repair mechanism that tends to introduce insertions or deletions
(indels) during repair23,35. When this occurs in an exon, null mutants are common. Whereas
HDR utilizes DNA from the undamaged sister chromosome or a donor DNA template to repair
the damaged chromosome. Thus, HDR can be used to induce incredibly precise mutations in
the genome. However, it is more difficult to exploit HDR for genome engineering because
studies have indicated that cells tend to be biased towards NHEJ36. Seeking to generate a
higher frequency of HDR repair events, researchers have done injections using flies with
inactivated DNA ligase IV, a ligase important in the NHEJ pathway. This change increased HDR
frequency by more than 3 times when compared to wild type36,37. Another study found that

8

the cell can be biased against NHEJ using RNA interference to inhibit DNA ligase IV38. This
approach was also successful in increasing the frequency of HDR events38. Additionally, HDR
requires a DNA donor template containing the desired modifications and homology arms,
approximately 1 kb of DNA upstream and downstream of the target site, to be co-injected with
the CRISPR components39. The template supplied will be used to repair the broken strand in lieu
of the homologous chromosome. Thus, while HDR can be used to generate extremely specific
edits, it is more labor intensive and is typically used after NHEJ editing protocols are established
in a species.
Site-specific DNA breakage technologies include, zinc finger nucleases (ZFNs),
transcription activator-like effector nucleases (TALENs), and most recently, the CRISPR/Cas
system. ZFNs and TALENs are engineered proteins that contain a DNA binding domain attached
to a separate cleavage domain. Both enzymes are engineered using the same cleavage domain,
the FokI nuclease, but different binding domains34,39,40. The FokI nuclease is a nonspecific
nuclease that is decoupled from the sequence of the DNA binding domain34,40,41. ZFNs have a
binding domain composed of three to six Cys2His2 zinc finger proteins41, each of which
recognizes and binds to three DNA bases. Whereas the TALEN binding domain is made up of
transcription activator-like effectors (TALEs)40 and each TALE recognizes and binds to just a
single DNA base. Thus, both technologies are highly customizable and enable researchers to
target nearly any sequence of DNA. However, when compared to the CRISPR/Cas system, these
technologies suffer major drawbacks which has led to a decline in their use. Both are complex
and labor intensive as each target site requires a new set of designer nucleases to be
generated. This is further complicated by the unpredictable efficiency and specificity of the
engineered binding domains which can change when zinc fingers or TALES are complexed
together42. Because of the drawbacks associated with ZFNs and TALENs, I chose to use the
CRISPR/Cas system to edit the genome of D. grimshawi for the first time.
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The CRISPR/Cas9 System
The discovery of the CRISPR/Cas9 system and its subsequent development for use in
genome editing has led to a renaissance for genome engineering in non-model organisms.
CRISPRs, or clustered regularly interspersed short palindromic repeats, were first discovered
only a few decades ago. In 1987, Yoshizumi Ishino a researcher at Osaka University in Japan was
studying the iap gene in the bacteria, Escherichia coli. As he studied the sequence, he noticed
string of non-random repeating segments of DNA. In his publication, he described the region of
repeats as an, “unusual structure” with unknown biological significance 43. However, it was not
until 2007 that the CRISPR/Cas system’s role in adaptive immunity of prokaryotes was fully
elucidated 44. It would take an additional five years before it would first be used as a tool for
genome editing45.
Within the endogenous organism, the CRISPR/Cas system serves to prevent reinfection
by past viruses44. The genomic region first mentioned in Ishino’s paper was discovered to be a
molecular record of past viral infections known as the CRISPR locus. During an infection, a short
segment of viral DNA is incorporated into the organism’s genome at the CRISPR locus which is
interspersed by palindromic repeating segments of native DNA. There are three necessary
components to prevent reinfection by a virus, the CRISPR RNA (crRNA), trans activating crRNA
(tracrRNA), and the Cas protein46. The crRNA is composed of an 18-nucleotide target site
transcribed from the CRISPR locus. The crRNA hybridizes with the tracrRNA, which contains the
stem loop structure that enables the formation of the ribonucleoprotein (RNP) complex with
the Cas enzyme. Together the crRNA and the tracrRNA form guide RNA (gRNA) which
complexes itself with Cas944,46. When the RNP complex is formed, it functions to protect these
cells’ progeny from reinfection by that same virus. If reinfection occurs, the crRNA target site
will Watson Crick base pair to the invading pathogen. However, cleavage by the Cas protein will
only occur if the protospacer adjacent motif (PAM) is present. The PAM site is three obligate
codons directly 5’ adjacent to the target site; for Cas9 the PAM site is ‘NGG’44–46 (Figure 3). The
site prevents autoimmune attack by the RNP complexes at the CRISPR locus. If present, the
PAM site triggers endonuclease activity by the Cas protein which acts as molecular scissors
inducing a double strand break in the invader’s DNA.
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CRISPR and Insects
Since CRISPR’s development for genome engineering in 2013, D. melanogaster has been
at the forefront of CRISPR’s application in insects enabling broader use of the technology in
non-model insects. Gratz et al. first demonstrated a large deletion in the D. melanogaster
yellow gene by co-injecting two sgRNAs and a short oligonucleotide donor sequence. However,
the approach suffered from low efficacy at just 5.9%47. Soon after, transgenic D. melanogaster
expressing Cas9 under control of the germline-specific nanos promoter were engineered and
crossed to flies expressing sgRNA ubiquitously. Crosses of the transgenic lines could produce a
desired mutant greater than 90% of the time48. However, outside of D. melanogaster this
approach is unrealistic and highly labor intensive. That same year, use of in vitro transcribed
Cas9 mRNA and sgRNA as injection components brought reported efficiencies to greater than
80%49–51. Additionally, Yu et al. found euchromatic and heterochromatic genes could be edited
by CRISPR at similar efficiencies 50. While working with Aedes aegypti, Kistler et al. found that
use of Cas9 protein instead of mRNA increased the rate of mutation by 5-10X52.
As new techniques continue to be developed, more and more insect species have been
successfully edited with CRISPR, many of which have helped expand our understanding of the
function of orthologous genes in non-model species. CRISPR was used in the swallowtail
butterfly Papilio xuthus making it just the second butterfly to have its genome edited, and the
first using CRISPR53. Since the establishment of CRISPR protocols for P. xuthus, researchers have
been able to highlight lineage specific discordance in the roles of highly conserved orthologous
pigment genes54. Further, Heinze et al. demonstrated the brown body locus in the housefly,
Musca domestica, is an ortholog of the D. melanogaster yellow gene using CRISPR55.
In 2015, gene drive, or “super Mendelian inheritance”, was fully realized using CRISPR in
D. melanogaster56. Termed mutagenic chain reaction (MCR), their gene drive uses autocatalytic
conversion to generate homozygous mutations at the target locus ensuring the desired
mutation becomes prominent in the population56. Groups working to control pest insects and
insect disease vectors are testing gene drive to manage the populations of these insects. Kyrou
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et al. found that CRISPR-Cas9 gene drive targeting doublesex, a gene important for sex
differentiation could suppress lab populations of the malaria vector Anopheles gambiae57. NHEJ
CRISPR protocols have been successfully implemented in the pest fly Drosophila suzukii, where
initial experiments knocked out the white and sex lethal genes with further research aimed at
using gene drive in the sex lethal gene to control invasive populations58.
With continued advances to CRISPR’s application in insects, one of the largest barriers
to using CRISPR in a species remains in how the CRISPR components are delivered. Like ZFNs
and TALENs, CRISPR’s application in insects has historically relied on delivery of gene editing
components via embryonic microinjection of pre-blastoderm embryos. Injections require
expensive equipment and extensive training to master the invasive technique59,60. Successful
studies typically report doing hundreds to thousands of injections because of the high death
rates associated with the technique. For example, after 240 embryo injections in the
agricultural pest Ceratitis capitata, 134 individuals hatched, and just 6 survived to adulthood60.
In the housefly study, Heinze reported injecting 2565 embryos and recovering only 188 adult
flies55. This has, until recently, greatly limited CRISPR in insects to species that lay eggs, can be
influenced to lay many eggs at a time, and have eggs that can survive the injection process59.
However, in 2018, Chaverra-Rodriguez et al. developed a novel CRISPR delivery technique as an
alternative to embryonic microinjections which they termed receptor-mediated ovary
transduction of cargo (ReMOT control)59.

A Novel CRISPR/Cas9 Delivery Approach: ReMoT Control
ReMOT control effectively avoids embryonic microinjections by exploiting a highly
conserved process known as vitellogenesis or yolk formation in eggs. Generally, during
vitellogenesis, yolk proteins, which are highly conserved, are synthesized in the fat bodies of
the organism. They are then secreted into the hemolymph and travel to the ovaries, where they
enter by receptor mediated endocytosis61,62. Then yolk proteins are packaged into eggs
undergoing vitellogenesis. The creators of ReMOT Control identified the ligand portion of the D.
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melanogaster yolk protein 1 gene that enables the protein to enter the ovaries, which they
termed P2C (DmP2C)59. They fused the DmP2C ligand to recombinant Cas9, which enabled the
CRISPR components to be injected into sexually mature females as opposed to the eggs
themselves. This approach not only circumvents embryonic microinjections but also potentially
allows for more than one individual’s genome to be edited per injection59.
ReMOT control was first developed and tested in the mosquito A. aegypti59. The kmo
gene was targeted with a reported effort efficiency defined as, the proportion of edited G0
offspring out of the number of individuals injected of approximately 30% and gene editing
efficiency of 1.5%59. With approximately one mutant generated per three females injected59.
Their reported injected survival rate dwarfed that of traditional CRISPR insect studies at an
astonishing 60-80%59. Furthermore, the authors reported biallelic editing by the Cas9 enzyme in
some offspring59 indicating that in some cases the Cas9 remained active long enough to edit
both the maternal and paternal allele of the gene target. Since ReMOT Control’s development
in 2018, many other species have been modified successfully using this approach. The malaria
vector Anopheles stephensi was genetically modified using the ReMOT control approach with
the same DmP2C ligand identified in the initial study63. However, A. stephensi females were
more negatively impacted by injection components than A. aegypti which may have influenced
the lower reported efficiency of 12.5%63. ReMOT control was attempted in the Silverleaf
Whitefly, Bemisia tabaci, a species with excessively small, delicate embryos, but was
unsuccessful using the DmP2C ligand64. However, an alternative ovary-targeting peptide
termed, BtKV, was identified in B. tabaci which allowed for the ReMOT Control CRISPR
approach to be successfully implemented at a reported efficiency of 71.43% 64.
The discovery of the CRISPR/Cas9 system and its subsequent development for use in
gene editing has started a renaissance for genetic studies of non-model organisms. However,
attempts to edit the genome of D. grimshawi remain unsuccessful. In comparison to D.
melanogaster, D. grimshawi produces eggs that are twice as large with an endochorion that is
eight times thicker65 which could present problems during embryonic microinjections. Further
D. grimshawi’s embryonic development is much slower with larvae taking more than two days
to hatch after eggs are laid. It is for these reasons that I chose to use the ReMOT Control
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CRISPR/Cas9 component delivery approach in lieu of embryonic microinjections to edit D.
grimshawi ‘s genome.

Purpose of this work
In this study, I aimed to, (1)
Design and build the tools for
CRISPR ReMOT control using the
DmP2C ligand identified by
Chaverra-Rodriguez et al.59(2)
Provide evidence that the D.
melanogaster derived fragment of
the Yp1 protein identified by
Chaverra-Rodriguez et al., is
capable of localizing in the ovaries
of three Hawaiian Drosophilidae
species: D. grimshawi, S. anomala,
and S. elmoi (Figure 4). (3)
Identify the ideal injection
conditions for highest editing
efficiency within D. grimshawi (4)

Figure 3. Schematic of ReMOT Control mediated delivery of CRISPR/Cas9
components to D. grimshawi oocytes

Characterize mutations
generated in D. grimshawi by CRISPR/Cas9 (5) Provide an outline for further application of the
ReMOT Control tool for functional gene characterization and novel gene discovery within D.
grimshawi. In doing this we can investigate many more questions surrounding the evolution of
this spectacular species and set the framework for implementing the approach in other
members of Hawaiian Drosophilidae.
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Materials and Methods
Fly Care
D. grimshawi flies were kept in a Percival incubator at 19C on a 12:12 light dark
schedule. Adult D. grimshawi flies were housed in large Drosophila breeding cages. They were
fed plates containing apple juice media supplemented with portions of Wheeler-Clayton toplayer media66. Every 48 hours flies were transferred into a clean cage and given fresh food
plates. Female flies preferentially lay their eggs on the Wheeler-Clayton portion of the plate
and thus, after removing plates, the Wheeler-Clayton top layer was transferred into a fresh vial
of Wheeler-Clayton food to allow larvae to develop. When 3rd instar larvae were observed in
the vial (7 – 14 days later), vials would be transferred to a pupation jar containing fine and
coarse sand mixed in a 3:1 ratio. Once adult individuals eclose in the jar, they are removed and
placed into a new breeding cage. Sexual maturity is reached roughly 14 days post eclosion.
During sexual maturation of newly eclosed flies, plates will tend to become moldy more quickly
and thus will be changed ever 24 hours during this time.
The Scaptomyza anomala and Scaptomyza elmoi flies were reared in vials containing
Wheeler-Clayton media66. Breeding adults were moved to new vials every 48 hours and old
vials containing eggs were kept for offspring to develop. Once 3rd instar wandering larvae were
observed in the removal vials, a damp piece of paper was inserted in the vial for larvae to
pupate on. Newly eclosed adult Scaptomyza flies were removed from papered vials and
transferred into vials containing apple juice media supplemented with yeast. Young flies were
kept on apple juice media until reaching sexual maturity (~5 days), at which point they would
be transferred to Wheeler-Clayton media.

Target Site selection:
I used the following criteria to select the sgRNA target sites within the y and w genes: (1)
target sites were 18 – 20 bp long and directly 3’ adjacent to an ‘NGG’ PAM site, (2) located
within an exon, (3) containing no exact or partial matches elsewhere in the genome, (4) and
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with a predicted low chance of off-target mutations. To search for target sites within the D.
grimshawi genome, I used the webtool CRISPR Optimal Target Finder
(http://targetfinder.flycrispr.neuro.brown.edu).

Single Guide RNA Production:
Guide RNA templates were designed following the protocol developed by Bassett et al49.
Double stranded DNA templates were first generated by template-free PCR using Phusion
polymerase. For all target sites, the forward primer contained the obligate T7 promoter site 5’
adjacent to the target site. The universal reverse primer contained the Cas9 associating CRISPR
RNA sequence. Templates were purified with the QIAquick PCR Purification Kit (Qiagen,d
28104). Template assembly was checked on a 1.5% agarose gel.
To generate the sgRNAs, I used the HiScribe T7 Quick High Yield RNA Synthesis Kit (NEB
E2050S) following the recommendations for short transcripts. 30 l reactions were assembled
at room temperature using approximately 1 g of dsDNA template per reaction to ensure
sufficient yields of sgRNA. The reactions were incubated at 37C for 16 hours overnight. Prior to
sgRNA purification, samples were treated with DNase for 15 minutes at 37C. The sgRNAs were
purified using the Monarch RNA Cleanup Kit (NEB, T2050L), and their concentration was
quantified using a Qubit 3.0 fluorometer (Invitrogen, Q33216).

In vitro sgRNA activity assay:
Following recommendations from New England BioLabs67, I first combined the sgRNA
with EnGen Spy Cas9 NLS (M0646M) in an equal molar ratio. I incubated the mixture at 25C for
10 minutes to allow the RNP complex to form. Then I added a PCR fragment containing the
sgRNA target site to the mixture. The final molar ratios of Cas9 to sgRNA to DNA was 10:10:1
for all reactions67. The reactions were incubated at 37C for at least 4 hours. Afterwards,
reactions were visualized on a 1% agarose gel.
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Plasmid Assembly:
The pET28a/Cas9-Cys (Addgene plasmid # 53261 ; http://n2t.net/addgene:53261 ;
RRID:Addgene_53261)68 plasmid containing Hexa-histidine tagged (His-tagged) recombinant
Cas9 was used to create two constructs pET28a-DmP2C-Cas9 and pET28a-DmP2C-mCherryCas9 (Figure 5). To assemble pET28a-DmP2C-Cas9, the plasmid was digested using restriction
enzymes BamHI and EcoRI. The linear plasmid was run on a 1% agarose gel and the fragment
was gel purified using the QIAquick (Qiagen, 28104). Oligos for generating the 123 bp DmP2C
fragment (NLQQQRQHGKNGNQDYQDQSNEQRKNQRTSSEEDYSEEVKN)59 were obtained from
ThermoFisher and assembled by template free PCR. An additional round of PCR was done to
introduce a BamHI site at the 5’ end of the fragment and an EcoRI site at the 3’ end of the
fragment. After PCR, the DmP2C fragment was purified and then double digested using BamHI
and EcoRI.
Plasmid ligation was done using a vector to insert molar ratio of 1:10. The reaction was
incubated at 20C overnight. Following the ligation, I dialyzed the plasmids for an hour against
sterile distilled water. Then I transformed the entire ligation reaction into electrocompetent
10Beta E. coli cells (NEB C3020K). Cells were plated on LB kanamycin (50g/ml) selection plates
and grown overnight at 37C.
To verify the assembly, ten colonies from the transformation plate were selected and
grown in 5 ml LB cultures supplemented with kanamycin (50g/ml). The cultures were
incubated at 37C with shaking overnight. Plasmids were purified from each culture following a
standard miniprep protocol. To crudely verify the desired insert had been ligated to the
plasmid, I ran PCR on each of the plasmid samples using primers designed to amplify the
DmP2C fragment. Afterwards, the reactions were run on an agarose gel and two candidates
were selected for verification by sequencing.
To assemble the pET28a-DmP2C-mCherry-Cas9 plasmid, I used PCR to attach a flexible
linker region to the mCherry cDNA at either end (Figure 4). The linker at the 5’ end followed the
design of Waldo et al. (GSAGSAAGSGEF) and the 3’ linker was a standard glycine serine linker
(GGSGGGSGG)69,70. In addition to linkers, an EcoRI site was added to the 5’ end of the mCherry
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cDNA and a SalI site was added to the 3’ end. Both the mCherry cDNA with linkers and the
pET28a-DmP2C-Cas9 plasmid were digested with EcoRI and SalI. Once the vector and insert had
been purified and verified by Sanger sequencing, the plasmid was ligated following the
procedure outlined above.

Figure 4. Plasmid assembly schematic. The original pET28a/Cas9-Cys plasmid was a gift from Hyongbum Kim.

Production of Recombinant Protein:
Verified plasmid was transformed into competent NEB BL21(DE3) E. coli cells
(Richmond, CA). Following successful transformation, a 50 ml LB broth starter culture
supplemented with kanamycin was inoculated with a single colony. Starter cultures were grown
overnight at 37C with shaking. The following morning, I used 10 mL of starter culture to
inoculate a one-liter Luria-Bertani broth culture71. The cells were grown at 30C with shaking
until the optical density reached 0.60. When this occurred, IPTG was added to the culture to a
final concentration of 0.3 mM to induce recombinant protein expression. The cells were kept at
30C with shaking for an additional 8 hours for expression to occur.
Following expression, cells were centrifuged at 11,000 x g f or 8 minutes at 4C. Pellets
were resuspended in 25 mL of lysis buffer (20 mM Tris-HCl, 500 mM NaCl, 20 mM imidazole)
and stored at -20 C overnight. The next day, cells were thawed on ice, and the solution was
briefly vortexed. Then lysozyme and protease inhibitors were added, and the mixture was
incubated on ice for 30 minutes. To further lyse cells, samples were passed through a French
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press 3 times at 18,000 psi. Then samples were centrifuged at 20,000 x g at 4C for 20 minutes.
The lysate was combined with Ni-NTA agarose in a flask and incubated at 4C with shaking for 1
hour to allow proteins to bind.
After incubation, the lysate-bead mixture was poured into a gravity flow column.
Proteins were washed three times with 5 ml of lysis buffer. Then proteins were eluted 5 times
using 2 ml of elution buffer (20 mM Tris-HCl, 500 mM NaCl, 250 mM imidazole) each time.
Protein fractions were placed in 50 kDa MWCO dialysis tubing and dialyzed at 4C with gentle
agitation in dialysis buffer (50 mM Tris-HCl, 300 mM KCl, 0.1 mM EDTA pH 8.0, protease
inhibitor cocktail). After 4 hours, the dialysis buffer was exchanged with fresh buffer and
proteins were left overnight. The following morning, the dialysis buffer was exchanged again,
and the proteins were dialyzed for an additional 4 hours. A centrifugal filter (50 kDa MWCO)
was used to concentrate the proteins (Amicon, UFC905024). Protein purity was checked on an
SDS PAGE gel. Protein was quantified by Qubit and Bradford Assay (Bio-Rad, 5000201) following
manufacturers’ instructions.

Single Fly DNA Extraction:
DNA was extracted from a single adult D. grimshawi fly following a protocol adapted
from Heinze et al., 201755. A single fly was frozen in a clean 1.5 ml Eppendorf tube at -20C for
20 minutes. 300 l of extraction buffer (0.1 M Tris-HCl pH 9, 0.1 M EDTA pH 8.0, 1% SDS) was
added to the sample and incubated at -20C for 5 minutes. After, samples were incubated at
70C for 30 minutes. 80 l of 8 M potassium acetate was added to samples and samples were
gently inverted for mixing. Samples were incubated on ice for 45 minutes and then centrifuged
at 13,000 x g at 4C for 15 minutes. The supernatant was transferred into a new 1.5 ml tube
and 175 l of room temperature isopropanol was added. Samples incubated at room
temperature for 5 minutes and then centrifuged at 14,000 x g at room temperature for 5
minutes. The supernatant was gently poured off and pellets were washed twice with 150 l of
70% ice cold ethanol. After centrifugation at 14,000 x g at room temperature for 3 minutes,
supernatant was poured off and tubes were inverted on a kimwipe for 15 minutes to dry the
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pellet. The pellet was resuspended in 100 l of TE buffer. DNA Concentration was quantified
with a Qubit 3.0 Fluorometer (Invitrogen, Q33216).

Time-course Evaluation of Egg production
To ensure CRISPR components can enter as many eggs as possible after injection, female
flies were fed on yeast and ovaries were dissected and imaged post-yeast feeding. This was
done for 12, 24, 36-, and 48-hours post-yeast feeding.

DmP2C-mCherry-Cas9 Injections:
To determine if the D. melanogaster derived P2C fragment of the Yp1 protein could
localize in D. grimshawi ovaries, I performed test injections using my P2C-mCherry-Cas9
fluorescent fusion protein. Microcapillary needles for all injections were pulled in Dr. K Adam
Bohnert’s lab in Baton Rouge, Louisiana using a Sutter P-1000 Micropipette Puller. Needles
were filled with injection mix composed of the P2C-mCherry-Cas9 protein (>1.0 g/ul) and 25
g/ml of the endosomal escape reagent (EER) saponin and fitted to an aspirator tube assembly
(Millipore Sigma, A5177). Control flies were injected with 1X PBS. Female flies were
anesthetized in the freezer and kept on ice during injection.
Flies were placed in an empty vial until they were conscious and then transferred to
Wheeler-Clayton vials for 24 hours prior to dissection66. To image ovaries for fluorescence, flies
were anesthetized using Fly Nap (173010, Carolina) and ovaries were dissected. A pair of
tungsten needles were used to tease out the ovarioles of one ovary per fly. I placed the ovaries
on a slide and added SlowFade Gold Antifade Mountant (S36936) to them and covered the
ovaries with a glass coverslip. Ovaries were visualized on a Nikon Eclipse E800 compound
microscope and images were captured using a Photometrics CoolSNAP DYNO camera.
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DmP2C-Cas9 Injections:
Newly eclosed virgin female D. grimshawi flies were removed from the population and
kept separately until reaching sexual maturity (~14 days). After reaching sexual maturity, flies
were considered ready for injection. I prepared the injection mix by combining my P2C-Cas9
protein (>2 g/l) with the selected sgRNAs (>200 – 1,200 ng/l). I incubated the injection
mixture at 25C for 10 minutes to allow the ribonucleoprotein (RNP) complex to form. After
RNP complexes had formed, I added the EER, saponin, which was prepared fresh just prior to
injections.
To inject adult flies, I followed the procedures outlined in the previous section. After
being injected, the flies were placed in an empty vial until they were conscious. Once awake,
flies were added to a breeding cage and 4-6 sexually mature males were added. Cages were
kept in the incubator and care was like that for non-injected flies. All eggs, larvae, and pupae
were segregated from the wild-type population. Following eclosion, F0 offspring were sexed and
inspected for altered phenotype. Since unremarkable F0 female offspring could be carrying a
mutated copy of the target gene, F0 females were mated to see if any mutant males occurred in
the F1 generation.

Mosaic Mutant Characterization:
F0 offspring exhibiting mosaic mutations were characterized using TA cloning following
the procedure outlined in the TA Cloning Kit with pCR 2.1 Vector (K202020). First, DNA was
extracted from potential mutants following the protocol outlined above. Each potential target
site was amplified with PCR using taq polymerase. Following PCR, amplifications were verified
on a 1% agarose gel. Once verified, the 10 l ligation reactions were set up and incubated at
room temperature for one hour.
Following ligation, each reaction was transformed into competent E. coli TOP10 cells.
For each transformation, I combined 2 l of the ligation reaction with 25 l of competent cells
and incubated the mixture on ice for 30 minutes. I then heat shocked the cells for 30 seconds at
42C and incubated the cells on ice for an additional 5 minutes. I added 250 l of SOC medium

21

to cells and placed them in a shaking incubator at 37C for an hour. Cells were plated on LB
Agar plates supplemented with 100 ug/ml of ampicillin and 40 l of 40 mg/ml X-Gal. Plates
were incubated overnight at 37C.
The following morning, plates were transferred to 4C to enable color development. For
each transformation, I selected 15 white colonies for isolation and analysis. Selected colonies
were grown overnight at 37C in LB Broth containing 100 ug/ml of ampicillin. Liquid cultures
were purified using the GeneJET Plasmid Miniprep Kit (K0502). I sent the purified plasmids for
sequencing at Eurofins Genomics.
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Results
Protein Expression and Purification
Ni-NTA agarose beads allow recombinant proteins to be isolated via affinity binding of
the His-tagged recombinant protein to the Na2+ ions on the beads72. However, non-specific
binding of host proteins does occur. Binding of non-specific proteins during purification
complicates the quantification of the target protein, which can further influence downstream
use of the protein. During initial purification trials of both the DmP2C-Cas9 and DmP2CmCherry-Cas9 proteins, I observed high
amounts of non-specific proteins co-

L

L

purifying with my target protein while
using the recommended Cas9 purification
buffers. To limit non-specific protein
binding, I increased the concentration of
NaCl in both the lysis and elution buffers
from 300 mM to 500 mM. This is because
an increase in salt concentration works to
decrease non-specific protein binding. While I
did observe a greater loss of my target protein,

Figure 5. An SDS gel showing purified DmP2C-Cas9 and
DmP2C-mCherry-Cas9 protein. A. Protein purification of
DmP2C-Cas9 and DmP2C-mCherry-Cas9 before (left) and
after (right) buffer salt concentration change. B. Purified
DmP2C-mCherry-Cas9 protein aliquot.

the purified products were significantly cleaner than previous purification attempts (Figure 5).

Target gene selection and sgRNA validation
For this project, I selected two genes as targets in the D. grimshawi genome. These
genes were selected because when they are mutated, an easily detectable phenotype is
exhibited. Furthermore, both genes are found on the X-chromosome, meaning mutant male
flies could be observed in the F0 generation. The first, Dgri\GH24338-RA, is an orthologue of the
D. melanogaster yellow (y) gene. The yellow gene is necessary for the conversion of black
melanin, which is present in the cuticle of adult flies and larval mouthparts73. yellow mutants
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can exhibit different phenotypes. Null mutants have a total loss of black melanin and adult flies
appear yellow in color. However, some mutations at the yellow locus exhibit mosaic expression
of yellow wherein the adult fly has only a partially altered phenotype73. y is located on the
reverse strand of scaffold_14853 (2,746,257 – 2,755,062) in the D. grimshawi genome
assembly. The gene has two exons, which are separated by a 4,368 bp intron (Figure 6).
The second gene I selected was Dgri\GH12272, an ortholog of the D. melanogaster
white (w) gene (Figure 6). white works as part of the production and transportation of red and
brown pigments found in the eyes of adult flies. w mutants have little to no pigmentation in
their eyes, causing them to appear white74. In the D. grimshawi genome assembly, white is
found on the reverse strand of scaffold_15203 (2,166,701 – 2,175,852). It has 6 exons and is
9.15 kb long (Figure 6). Previous research has revealed variable efficiencies between sgRNAs
targeting different regions of the target gene49. For that reason, I selected four target sites to
test in each of my target genes (Figure 6).

Figure 6. Structural features of selected target genes. Arrows indicate approximate location of selected target site in the
gene. Target site sequence for each selected site.

To verify my sgRNA design and assembly, I conducted an in vitro activity assay for each
sgRNA. Seven out of eight of my sgRNAs were able to be validated (figure 7). A single w sgRNA,
w684, was not able to be validated after multiple attempts, and was thus excluded from further
injections.
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Figure 7. in vitro validation of selected yellow gene sgRNAs (left) and white gene sgRNAs (right)

Yolk proteins enter the oocyte during vitellogenesis by receptor-mediated endocytosis
(RME) in clathrin-coated vesicles75. Co-option of RME to deliver exogenous macromolecules
successfully requires the inclusion of an endosomal escape reagent (EER) to release the cargo
from the endosome76. However, EER reagents are typically harmful to the cell and a balance
must be struck between concentration and toxicity77. The EER saponin has been used
successfully in multiple ReMOT Control based studies previously63,64. However, when used at
higher concentrations, it greatly increased mortality of the injected individuals63. To investigate
the effects of saponin concentration on injected female D. grimshawi mortality, I tracked
mortality following injection of saponin at five different concentrations (Figure 8). Saponin was
well tolerated at the lowest concentration (25 g/ml), with 81% of injected flies still alive 72hours after injection. However, I observed an increase in mortality at all higher concentrations,
indicating a threshold effect for saponin toxicity in D. grimshawi.
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Female D. grimshawi Post-injection Survival

Saponin Concentration and Adult Female Survival Over
Time
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Figure 8. The survival of female D. grimshawi flies 72- hours post-injection of different concentrations of
saponin. (100 mg/l n= 18, 75 mg/l n= 17, 60 mg/l n= 57, 50 mg/l n=10, 25 mg/l n=21)

Highly conserved ligand enables CRISPR/Cas9 delivery to the developing oocytes
To determine the optimal injection time, I conducted a time course evaluation of egg
production post-yeast feeding. Drosophila species have polytrophic meroistic ovaries. Each
ovary is composed of multiple ovarioles, that produce eggs via their own stem cell population 78.
Ovariole numbers exhibit considerable interspecies variation, depending on level of
specialization, organism size, and other factors. D. grimshawi is a member of the picture-wing
clade of Hawaiian Drosophila where the majority of members in this group oviposit on decaying
bark in large batches at a time3. D. grimshawi has an average of 23.9 ovarioles per ovary3,78. Egg
development is a 14-stage cycle that occurs asynchronously and independently within each
ovariole 78,79. During the development of an oocyte, vitellogenesis begins at stage 8 and ends at
stage 1039. This indicates the ideal time for CRISPR component injection is just prior to stage 8
in as many ovarioles as possible. To encourage oviposition in D. grimshawi, female flies were
fed yeast paste. Ovaries were dissected following yeast feeding to determine if yeast could be
used to enrich the ovaries with pre-vitellogenic egg chambers. While flies fed on yeast tended
to have fewer fully formed eggs in their ovaries when compared to control flies, no yeast-fed
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group consistently had fewer fully formed eggs than others, suggesting that yeast should be
used to encourage oviposition and oocyte development in D. grimshawi females. However,
yeast feeding time should still be varied to further investigate if it could increase the mutation
efficiency.
Evolutionary divergence between Drosophila melanogaster, a member of the subgenus
Sophophora, and the Hawaiian Drosophilidae is approximately 40 million years81. While yolk
proteins have been previously studied in picture-wing flies, including in D. grimshawi82,83,
recognition of the DmP2C ligand fragment by the Hawaiian Drosophilid vitellogenin receptor’s
needed to be confirmed. To test this, I constructed the pET28a-DmP2C-mCherry-Cas9 plasmid
and expressed the recombinant fluorescent fusion protein in BL21(DE3) E. coli cells (NEB
C2527H). The protein was
injected into sexually mature
female D. grimshawi, S. elmoi,
and S. anomala flies. To
minimize mortality,
intrathoracic injections were
done by inserting the needle
between the supraalar bristles
(SA1, SA2) and the presutural
bristles (PS) on the right or left
side of the fly’s thorax84,85 and
slowly injecting until fluid

Figure 9. D. grimshawi fly showing properly placed needle for intrathoracic
injections of the CRISPR/Cas9 machinery

would no longer enter the fly
(Figure 9). When placed in the proper location, there will be little resistance, as if the needle
was inserted in a hole. Control flies were injected with 1X phosphate-buffered saline (PBS).
Ovaries were dissected 24 hours after injection and examined for mCherry fluorescence. Noninjected fly ovaries were also visualized for comparison (Figure 12).
In the DmP2C-mCherry-Cas9 injected ovaries, I observed fluorescent ‘yolk granules’ in
oocytes undergoing vitellogenesis as well as oocytes that had completed vitellogenesis. I also
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observed a large volume of fluorescent puncta aggregating outside of oocytes undergoing
vitellogenesis throughout the injected ovaries. Fluorescence was present in the injected ovaries
of all three fly species tested, suggesting that the DmP2C fragment can be used to access
developing oocytes in S. elmoi, S. anomala, and D. grimshawi (Figure 10 & 11). Fluorescent
speckles believed to be yolk granules and fluorescent puncta outside of the eggs were not
observed in the non-injected and PBS control fly ovaries (Figure 12).

Figure 10: Brightfield and mCherry fluorescent images of ovaries dissected from S. elmoi and S. anomala flies injected with
DmP2C-mCherry-Cas9 protein. Arrows in the brightfield view indicate to an egg undergoing vitellogenesis. The arrows in the
TRITC view show fluorescent yolk inside of the same developing oocytes.
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Figure 11. Brightfield and mCherry fluorescent images of ovaries dissected from D. grimshawi flies (n=25) 24-hours post-injection
of the DmP2C-mCherry-Cas9 protein. Arrow points to an egg in late stage vitellogenesis in the brightfield view. In the TRITC
view, arrow points to fluorescent yolk inside of the late stage vitellogenic oocyte.

Figure 12. Brightfield and mCherry fluorescent images of ovaries dissected from D. grimshawi files. Non-injected (left) and PBS
injected (right)
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DmP2C-Cas9 injections
In total, I injected 503 D. grimshawi females with the DmP2C-Cas9 protein, with varied
combinations of sgRNA and the EER saponin (Table 4). I recovered 526 offspring from the F0
generation. Of those offspring, three male individuals exhibited a w mosaic phenotype (Figure
13). None of the individuals recovered exhibited a y mutant phenotype. All the presumed
mutants were dead when they were discovered. However, since both y and w are x-linked
traits, female F0 flies were assumed to have a mutated maternal chromosome that could result
in her male progeny expressing a mutant phenotype. Thus, F0 females expressing a WT
phenotype were mated to WT males. From those crosses, I recovered 203 total F1 offspring,
none of which presented a mutant phenotype (Table 5). My overall mutation rate based on the
three potential mutants recovered is 0.57%.
To verify and characterize the mosaic mutants, I used TA cloning to try and recover a
mutated copy of the w gene. Thus far I have sequenced 20 clones using DNA fragments
amplified from the AI25SAP mutant. I chose this mutant to sequence because their eyes
exhibited the greatest proportion of white pigment, suggesting more of its somatic cells may be
carrying a mutated version of the w gene. However, none of the clones sequenced provided
evidence that the w gene was mutated in the AI25SAP individual.

Figure 13. Three recovered putative male mosaic w mutants. AI25SAP was an F0 progeny of a female injected
with all the sgRNAs and 25 ug/ml of saponin. WI15SAP was an F0 progeny of a female injected with w sgRNAs
and 15 ug/ml of saponin.
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Ovaries dissected from DmP2C-Cas9 injected females contain globules in oocytes
DmP2C-mCherry-Cas9 injected ovaries exhibited globules aggregating outside of
developing oocytes (Figure 14C). Thus, ovaries were dissected to check for the presence of
globules in non-injected flies as well as DmP2C-Cas9 injected flies (Figs. 14A&B). Ovaries
dissected 32 hours after DmP2C-Cas9 injection exhibited small globules surrounding developing
oocytes (Figure 14A). Further, multiple oocytes contained globules and/or had unequal yolk
distribution (Figure 14A). Ovaries dissected 72 hours after DmP2C-Cas9 injection contained
almost no vesicle-like aggregates outside the oocytes (Figure 14A). However, oocytes still
exhibited uneven yolk distribution throughout the egg. In some oocytes, yolk had retracted
from the posterior pole of the egg (Figure 14A). In contrast, non-injected fly ovaries contained
no vesicle-like aggregates outside of developing oocytes (Figure 14B). Yolk was evenly
distributed throughout the egg with no large gaps between eggs and the outer membrane
(Figure 14B).

Figure 14. A comparison of globule presence in the ovaries of injected and non-injected D. grimshawi flies. A) Dissected D.
grimshawi ovaries following DmP2C-Cas9 injection show evidence of uneven yolk distribution (green arrows), yolk retraction
from the poles of the oocyte (red arrow) and globule formation in the oocyte (blue arrow). B) Non-injected D. grimshawi ovary
with even distribution of yolk in each oocyte and no apparent globules present in the ovary. C) DmP2C-mCherry-Cas9 injected D.
grimshawi ovariole with large globule attached (red arrow).
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Discussion
As it stands, this work has established that the DmP2C ligand can access developing
oocytes in three different Hawaiian Drosophilidae species. This work has also shown that both
constructs (DmP2C-mCherry-Cas9, DmP2C-Cas9) as well as 7 of my 8 sgRNAs were designed and
assembled properly. However, this work has not been able to illustrate successful application of
CRISPR/Cas9 via ReMOT Control in D. grimshawi. Two of the three remaining potential mosaic
mutants remain to be sequenced and should potentially still be investigated. However,
validating any mutant seems unlikely since no F1 male progeny exhibited a w mutant
phenotype. An alternative explanation is that because the three putative mutants were found
dead, the lack of pigment observed in parts of the eye was caused by rapid decomposition of
the fly after death. This decomposition may have led to the breakdown of red eye pigments and
the bleaching of the eye86. This conclusion is partially supported by my lab observations of
white pigment appearing following the death of wild-type flies. If this is the case, there are
many possible explanations for why we were unable to obtain a mutant that we are beginning
to explore further.
First, multiple studies have reported a positive correlation between sgRNA
concentration and editing efficiency42,59,63 of Cas9 in both embryonic microinjection-based
experiments as well as ReMOT Control-based experiments. During my injections, I primarily
used sgRNAs that were in the range of 200 – 500 ng/l. One could argue that increasing
injected sgRNA concentration could effectively increase the editing efficiency in D. grimshawi.
Thus, I have begun injecting flies using sgRNAs targeting the y gene (Y106 & Y827) with a
concentration range of 850-1,100 ng/l (Table 4). When y is mutated, an altered phenotype can
be observed in the larval mouthparts. Wild type larvae exhibit black mouthparts whereas
mutants will have yellow pigmented mouthparts. I have not observed any larval mutants in my
ongoing high sgRNA injection group. Thus, my preliminary results using highly concentrated
sgRNAs in D. grimshawi flies do not currently support the argument that sgRNA concentration
was responsible for the low editing efficacy I observed. However, we should continue to inject
at higher concentrations to test this further.
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The researchers who developed ReMOT Control first tested and confirmed the novel
delivery approach using the mosquito species, A. aegypti59. Aside from the highly conserved
low density lipoprotein receptor which allowed the D. melanogaster derived P2C fragment to
enter developing oocytes in both A. aegypti and D. grimshawi, key differences in vitellogenesis
exist between these species and more generally between mosquitoes and higher
dipterids61,80,87. These differences could help explain the unsuccessful application of ReMOT
Control in D. grimsahwi. Many mosquito species including A. aegypti produce eggs in batches
anautogenously88,89. This means just prior to vitellogenesis oocyte development diapauses88.
Oocytes do not enter vitellogenesis until the female obtains a bloodmeal, at which point, all
oocytes enter vitellogenesis at the same time88.
In contrast, D. grimshawi and Drosophila oocytes in general develop asynchronously and
egg chambers at varying stages of development can be observed throughout the ovary. Higher
Diptera like D. grimshawi synthesize multiple comparatively smaller (~50 kDa) yolk proteins
(YP1, YP2, YP3) in the fat body as well as in follicle cells of the ovary80,83,90. Yolk protein
synthesis occurs asynchronously during vitellogenesis and the amount of each protein
synthesized varies in both the fat body as well as the ovarian follicle 83. Furthermore, Drosophila
yolk proteins are not homologous to the vitellogenins synthesized by mosquitoes and other
insects, which are large (<200 kDa) phospholipoglycoproteins87.One cannot discount the
possibility that my observed low editing efficiency in comparison to the original study is the
result of having significantly less control over vitellogenesis timing in D. grimshawi, which may
continue to present challenges going forward.
Previous studies on vitellogenesis in Drosophila flies have found that expression and
secretion of yolk proteins occurs in parallel with the expression and secretion of the vitelline
membrane proteins (VMPs)75,91,92. Electron microscopy of D. melanogaster follicle cells showed
that during co-secretion VMPs and yolk proteins are packaged into separate discrete vesicles
that differ in density91. Less densely packed vesicles were found to contain VMPs and vesicles
higher in density were packaged with yolk proteins in multisubunit complexes91,92.
In two studies on the effect of mutant yolk proteins in D. melanogaster, specifically
fs(1)1163 in YP1 and fs(1)K313 in YP2 found in female D. melanogaster, mutant yolk proteins
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precipitated and accumulated in the basement membrane of the fat body as well as the subvitelline membrane92,93. The precipitate in the sub-vitelline membrane prevented proper
formation of the vitelline membrane, causing eggs to collapse in on themselves and making
mutant females effectively sterile92,93. The severity of the mutant phenotype differed between
the YP1 and YP2 mutants. In the YP2 mutant, a single amino acid substitution occurred at
position 141 from a proline residue (alipathic, non-polar) to a leucine residue (alipathic, nonpolar)92. The YP2 mutant was less severe than YP1, which had a single amino acid substitution
at position 92, from isoluceine (non-polar, alipathic) to asparagine (polar, non-charged)92,93.
These differences could be explained by a greater conformational change in the folding of YP1,
preventing proper assembly of tertiary structure. This could cause less dense packaging during
RME by the yolkless receptor and premature exocytosis from the vesicle causing, globules to
form91–93.
Thus, an alternative explanation that is in part supported by my results may be that the
ReMOT Control CRISPR/Cas9 delivery approach using the DmP2C ligand is not viable within D.
grimshawi flies. This is not caused by a lack of recognition of the DmP2C ligand by the D.
grimshawi yolkless low density lipoprotein receptor, but rather it may be due to incorrect
sorting or inefficient packaging of the DmP2C-Cas9 fusion protein during receptor mediated
endocytosis80,91. The DmP2C-Cas9 protein is predicted to fold less tightly than wild type yolk
proteins which will cause the vesicles that the DmP2C-Cas9 protein are packaged into to be less
dense than if they were packaged with wild type yolk proteins. Less dense packaging could have
resulted in premature exocytosis-like event from the vesicle during transport into the oocyte
similar to what happened in the D. melanogaster YP1 and YP2 mutants. Thus, I hypothesize that
ReMOT Control CRISPR/Cas9 editing approach using the DmP2C ligand caused transient female
sterility in D. grimshawi, S. anomala and S. elmoi. This was caused by less dense folding of the
construct and thus inefficient packaging into vesicles which resulted in premature exocytosis
from vesicles during transport, interfering with vitelline membrane formation.
This explanation is at least in part supported by the presence of large masses located at
the proximal and distal ends of egg chambers in my DmP2C-mCherry-Cas9 injected flies (Figs.
10, 11 &14). The globules and retracted yolk observed in DmP2C-Cas9 injected individuals also
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supports this hypothesis (Figure 14A).This is in contrast to non-injected flies which do not
contain any sort of globules in their ovaries (Figs. 12 &14B)90–93. It is also supported by my
observation that eggs laid soon after injection usually did not develop. While D. grimshawi
females would begin to lay eggs around 24 hours after injection, eggs collected 1-3 days postinjection would rarely hatch. This could be attributed to the time it takes for all injected protein
to be packaged into eggs, broken down, and/or excreted. We are working to investigate this
phenomenon quantitatively as we continue to test ReMOT Control in D. grimshawi.
To investigate this new hypothesis further, an immunofluorescence assay like the one
described by Chaverra-Rodriguez et al., should be conducted59. This would allow us to confirm
the globules within and surrounding the oocytes of DmP2C-Cas9 and DmP2C-mCherry-Cas9
injected individuals contained our precipitated Cas9 construct. Additionally, we should begin
conducting ReMOT Control test injections in D. melanogaster using both of our constructs. If we
observe similar precipitates in injected D. melanogaster ovaries, this will provide further
support to the possibility that co-option of the yolkless receptor for CRISPR/Cas9 in higher
dipterids is not possible due to transient sterility following injection. Furthermore, multiple
sgRNAs have been validated in D. melanogaster, enabling quicker design and greater
confidence in a mutation being generated at the target site.
Hawaiian Drosophila remain a fascinating and complex evolutionary model clade that
we intend to continue to work with. Though we have not yet obtained a mutant using the
ReMOT Control CRISPR/Cas9 delievery approach, we plan to keep trying. If we find that
transient sterility is caused by using the ReMOT Control approach with the DmP2C ligand in
higher dipterids, we believe there may be an alternative ligand receptor pair that could be coopted for use in D. grimshawi.
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Tables
Table 1: Primers used to generate dsDNA templates of my selected sgRNA target sites. sgRNA target site sequence is shown in
red

Target
Site
White
684
White
113
White 52
White
319
Yellow
1423
Yellow
827
Yellow
106
Yellow
111
Universa
l Reverse
Primer

sgRNA dsDNA template Primers (5’ -> 3’)
GAAATTAATACGACTCACTATAGGCACCCCAATAATCGTATGCGTTTTAGAGCTAGAAATAGC
GAAATTAATACGACTCACTATAGGCTAATGCAGCTCTGCGAAGGTTTTAGAGCTAGAAATAGC
GAAATTAATACGACTCACTATAGGTGCAACTGCTCGGTAGAGTTTTAGAGCTAGAAATAGC
GAAATTAATACGACTCACTATAGGAGATGCTTGCGCGGTGCGTTTTAGAGCTAGAAATAGC
GAAATTAATACGACTCACTATAGGATATGCTCTGCCCGGACGAGTTTTAGAGCTAGAAATAGC
GAAATTAATACGACTCACTATAGGCGCAGGATGCGCGTGGAGAGTTTTAGAGCTAGAAATAGC
GAAATTAATACGACTCACTATAGGCTTGAGCCTCTCATTTGGGAGTTTTAGAGCTAGAAATAGC
GAAATTAATACGACTCACTATAGGCTCCTTGAGCCTCTCATTTGTTTTAGAGCTAGAAATAGC
AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCT
CTAAAAC

Table 2. Primers used to amplify gene regions harboring selected target sites

Target Site
Primers
yellow gene
YE1S1
YE1S2
YE2S1
YE2S2
white gene
WE1
WE2
WE3

Forward (5' -> 3')

Reverse (5' -> 3')

Product
Length (bp)

TGGCTGCTGGTTCAACTCAA

GCTGGAGCGCCAACTCTAAA

GTGGTCCGTGGCAAAAGTT
G
GGTACTCGATACGGGCACTG
ATGTCGGTCTCGTGTTTCCC

AGCGGGGAACTGTGACAAAT

323
292

GTCGCAGATACGATGGCTGA
AATTCTTGAGTCCCTCCCGC

953
555

TGTGTTTTGTCAGCGCGTTC
CGAACAACAACCCTGCCAAG
ACGACCCTATTGAACGCGTT

CTGTGAGTGCGGGATTTGTG
GCCAACAGTTCACCCGGATA
CACAAGCGGCACGGTTAAAA

501
911
2225
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Table 3. Primers used for assembling the DmP2C-mCherry-Cas9 and DmP2C-Cas9 constructs
Plasmid
Assembly
Primers
DmP2C
Assembly
DmP2C
Restriction
Enzyme
sites
mCherry
Amplificati
on
mCherry
Flexible
Linkers

Forward (5' -> 3')

Reverse (5' -> 3')

GATCCAATCTGCAGCAGCAGCGCCAGCACGGCAAGAACGGCAACC
AGGACTACCAGGATCAGAGCAACGAACA
GCGGGATCCAATCTGCAGCAG

GTTCTTAACCTCCTCGCTGTAGTCCTCCTCGCTGCTGGTCCTCT
GGTTCTTCCTCTGTTCGTTGCTCTGATCC
GCCGAATTCGTTCTTAACCTCCTC

GTGAGCAAGGGCGAGGAGGATA

CTTGTACAGCTCGTCCATGCCG

CCGGAATTCGGTAGCGCAGGCTCTGCGGCAGGTTCTGGTGAATTT
GTGAGCAAGGGCGAGGAGGATAAC

CGGGTCGACGGAGCTCGCTGCCACCGCCACCCTTGTACAGCTC
GTCCATGC

Table 4. DmP2C-Cas9 injection tracking using saponin for endosomal escape. Asterix indicate current injections which have been
injected 3 separate times using sgRNA at concentrations greater than 850 ng/ul. Larval offspring of these individuals have thus
far not exhibited a y mutation, which can be determined by the presence or absence of black melanin in larval mouth parts.

Total
females
injected (F1)

Gene Target

Saponin
Concentration
(ug/ml)

Yeast
Timing

Male
Offspring
(F0)

Female
offspring
(F0)

Total
offspring
(F0)

mutant
s

44

white

25

53

62

115

0

36

white

15

22

31

53

2

32

white

35

0

0

0

0

33

white

30

0

0

0

0

24

white

60

0

0

0

0

60

yellow

25

22

43

65

0

40

yellow

30

14

18

32

0

33

yellow

60

0

0

0

0

106

yellow &
white
yellow &
white
Yellow*

25

Yeast
after
Yeast
after
Yeast
before
Yeast
before
Yeast
before
Yeast
before
Yeast
before
Yeast
before
Yeast
before
Yeast
before
Yeast
before

118

122

240

1

10

11

21

0

*

*

*

*

239

287

526

3

74
21

15
25

Total
503
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Table 5. F1 generation of 3 injection groups.

Generation Injection
group

Male
offspring

Female
Offspring

Total
Offspring

Number of
mutants

F1

WI25 SAP

23

22

45

0

F1

WI15 SAP

41

43

84

0

F1

YI25 SAP

33

41

74

0

97

106

203

0

Total

38
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